FDA warns of cybersecurity vulnerabilities in Hospira Symbiq Infusion SystemIn a safety communication circulated on its website, the FDA alerts users of the Hospira Symbiq Infusion System to cybersecurity vulnerabilities with this infusion pump. "We strongly encourage that health care facilities transition to alternative infusion systems, and discontinue use of these pumps," the FDA stated. Reference Link